Below are the most recent publications written about "Renal Insufficiency, Chronic" by people in Profiles.
-
Abu HO, Del Castillo FF, Wang W, Saczynski JS, Mehawej J, Tenes P, Tisminetzky M, Gurwitz J, Goldberg RJ, Dosa D, Kapoor A, McManus DD. The prevalence and burden of chronic kidney disease, patterns of anticoagulation prescribing, and major bleeding risk in older adults with atrial fibrillation. BMC Geriatr. 2025 Dec 28; 26(1):138.
-
Asirwatham A, Oliphant M, Kovell LC, Ahmed H, Kurland J, O'Connor MJ, Juraschek SP, Wilkie G. Secondary hypertension diagnosis and management among pregnant patients: a review. Am J Obstet Gynecol MFM. 2025 Dec; 7(12):101813.
-
Park J, Han K, Kim B, Lee K, Jang HR, Yoon JM, Lim DH, Shin DW. Risk of age-related macular degeneration according to the chronic kidney disease and proteinuria in Korea: a 10-year nationwide cohort study. Sci Rep. 2025 Jul 22; 15(1):26595.
-
Tsang YP, Aryeh KS, Wang K, Himmelfarb J, Yeung CK, Kelly EJ. Enhancing therapeutic strategies and drug development for patients with kidney disease. Expert Opin Drug Saf. 2026 Jan; 25(1):23-48.
-
Mattocks KM, Walker L, Kroll-Desrosiers A, Crowley S, Moore DT, Bonegio R. Assessing Rural Veterans' Experiences with a Tele-Nephrology Program in the Veterans Health Administration. Am J Nephrol. 2026; 57(2):272-279.
-
Ostermann M, Corteville DC, Doi K, Koyner JL, Lamy A, Li G, Solinsky CM, Winterberg PD, Smith WT, Mehta RL, Murray PT, Shaw AD, Zarbock A, Engelman DT. A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS). Trials. 2025 May 30; 26(1):181.
-
Vieira de Oliveira Salerno PR, Lewis PGT, Chen Z, Dazard JE, Ganatra S, Ahmed EN, Nasir K, Deo SV, Rajagopalan S, Al-Kindi S. Climate Vulnerability and Cardiovascular-Kidney-Metabolic Disease in the United?States. J Am Heart Assoc. 2025 Jun 03; 14(11):e038251.
-
Colletta A, Cooper KM, Placentino G, Devuni D, Colletta C. Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic liver disease and type 2 diabetes. Front Endocrinol (Lausanne). 2025; 16:1531295.
-
Goyal A, Saeed H, Sulaiman SA, Sultan W, Siddiqui MR, Kan Changez MI, Qamar A, Ganatra S, Dani SS. Emerging trends and disparities in cardiovascular, kidney, and diabetes-related mortality: A retrospective analysis of the wide-ranging online data for epidemiologic research database. PLoS One. 2025; 20(5):e0320670.
-
Safarova MS, Weintraub S, Sadaniantz K, Kovell L, Warden BA, Garshick MS, Duell PB, Gianos E. Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults. Curr Atheroscler Rep. 2025 May 01; 27(1):54.